Zoetis Inc. SWOT

Zoetis Inc. is a global animal health firm headquartered in Parsippany, New Jersey, United States. The company was formerly a Pfizer subsidiary, but since Pfizer spun off its 83% ownership stake in the company in 2012, Zoetis became independent. The Company's main areas of concentration are the research, development, production, and commercialization of drugs, vaccines, diagnostic tools, biodevices, genetic tests, and precision animal health technology. It sells products for eight main species, including cattle, swine, poultry, fish, and sheep in addition to dogs, cats, and horses. It also sells products in the categories of vaccines, anti-infectives, parasiticides, dermatology, other pharmaceuticals, medicated feed additives, and animal health diagnostics. The United States and International are its two operational divisions. It provides a product line, including Alfaxan, for both livestock and companion animal consumers within each of these operating sectors. In October 2022, Zoetis announced that it had been named to Fortune's 2022 Change the World list. As of 2023, it has 13,800 employees worldwide.

The unique selling proposition of Zoetis Inc. is that it is the largest manufacturer of drugs and vaccines for livestock and pets in the world. The mission statement of Zoetis Inc. reads, "to nurture the world and humankind by advancing care for animals".